Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Background: In the Phase III CALIMA trial, benralizumab significantly reduced asthma exacerbations, increased lung function, and alleviated symptoms for patients with severe, uncontrolled eosinophilic asthma. The aim of this subgroup analysis was to evaluate the efficacy and safety of benralizumab f...

Full description

Bibliographic Details
Main Authors: Ken Ohta, Mitsuru Adachi, Yuji Tohda, Tadashi Kamei, Motokazu Kato, J. Mark Fitzgerald, Masayuki Takanuma, Tadahiro Kakuno, Nobuyuki Imai, Yanping Wu, Magnus Aurivillius, Mitchell Goldman
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Allergology International
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893017301570

Internet

http://www.sciencedirect.com/science/article/pii/S1323893017301570

Similar Items